Effects of exogenous desmopressin on a model of heat stress nephropathy in mice

American Journal of Physiology - Renal Physiology

Volumn 312, Issue 3, 2017, Pages F418-F426

  Roncal Jimenez, Carlos A ^a   Milagres, Tamara ^a   Andres Hernando, Ana ^a   Kuwabara, Masanari ^a   Jensen, Thomas ^a   Song, Zhilin ^a   Bjornstad, Petter ^a   Garcia, Gabriela E ^a   Sato, Yuka ^a   Sanchez Lozada, Laura G ^b   Lanaspa, Miguel A ^a   Johnson, Richard J ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b Laboratory of Renal Physiopathology   (Mexico)

Author keywords

Chronic kidney disease of unknown etiology; Copeptin; Mesoamerican nephropathy; Vasopressin

Indexed keywords

ALDEHYDE REDUCTASE; CREATININE; DESMOPRESSIN; MONOCYTE CHEMOTACTIC PROTEIN 1; AMMONIA; ARGIPRESSIN[1 DEAMINO]; BIOLOGICAL MARKER; FRUCTOKINASE; VASOPRESSIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; HEAT STRESS; HEAT STRESS NEPHROPATHY; KIDNEY CONCENTRATING CAPACITY; KIDNEY DISEASE; KIDNEY FUNCTION; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; UREA NITROGEN BLOOD LEVEL; URINE OSMOLALITY; AGONISTS; ALBUMINURIA; ANIMAL; BLOOD; C57BL MOUSE; CHEMICALLY INDUCED; CHRONIC KIDNEY FAILURE; COMPLEMENT ACTIVATION; COMPLICATION; DEHYDRATION; DISEASE MODEL; DRUG EFFECTS; ELECTROLYTE BALANCE; FIBROSIS; HEAT INJURY; KIDNEY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; RISK FACTOR;

ALBUMINURIA; ALDEHYDE REDUCTASE; AMMONIA; ANIMALS; BIOMARKERS; BLOOD UREA NITROGEN; COMPLEMENT ACTIVATION; CREATININE; DEAMINO ARGININE VASOPRESSIN; DEHYDRATION; DISEASE MODELS, ANIMAL; FIBROSIS; FRUCTOKINASES; HEAT STRESS DISORDERS; KIDNEY; MALE; MICE, INBRED C57BL; RECEPTORS, VASOPRESSIN; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; WATER-ELECTROLYTE BALANCE;

EID: 85014715080     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00495.2016     Document Type: Article

References (36)

1. Amlal H, Sheriff S, Faroqui S, Ma L, Barone S, Petrovic S, Soleimani M. Regulation of acid-base transporters by vasopressin in the kidney collecting duct of Brattleboro rat. Am J Nephrol 26: 194–205, 2006. doi:10.1159/000093305.
2. Bankir L, Bouby N, Ritz E. Vasopressin: a novel target for the prevention and retardation of kidney disease? Nat Rev Nephrol 9: 223–239, 2013. doi:10.1038/nrneph.2013.22.
3. Bardoux P, Bichet DG, Martin H, Gallois Y, Marre M, Arthus MF, Lonergan M, Ruel N, Bouby N, Bankir L. Vasopressin increases urinary albumin excretion in rats and humans: involvement of V2 receptors and the renin-angiotensin system. Nephrol Dial Transplant 18: 497–506, 2003. doi:10.1093/ndt/18.3.497.
4. Bardoux P, Martin H, Ahloulay M, Schmitt F, Bouby N, Trinh-Trang-Tan MM, Bankir L. Vasopressin contributes to hyperfiltration, albuminuria, and renal hypertrophy in diabetes mellitus: study in vasopressin-deficient Brattleboro rats. Proc Natl Acad Sci U S A 96: 10397–10402, 1999. doi:10.1073/pnas.96.18.10397.
5. Bouby N, Ahloulay M, Nsegbe E, Déchaux M, Schmitt F, Bankir L. Vasopressin increases glomerular filtration rate in conscious rats through its antidiuretic action. J Am Soc Nephrol 7: 842–851, 1996.
6. Burg MB. Molecular basis of osmotic regulation. Am J Physiol Renal Fluid Electrolyte Physiol 268: F983–F996, 1995.
7. Cirillo P, Gersch MS, Mu W, Scherer PM, Kim KM, Gesualdo L, Henderson GN, Johnson RJ, Sautin YY. Ketohexokinase-dependent metabolism of fructose induces proinflammatory mediators in proximal tubular cells. J Am Soc Nephrol 20: 545–553, 2009. doi:10.1681/ASN. 2008060576.
8. Clark WF, Sontrop JM, Huang SH, Moist L, Bouby N, Bankir L. Hydration and Chronic Kidney Disease Progression: A Critical Review of the Evidence. Am J Nephrol 43: 281–292, 2016. doi:10.1159/000445959.
9. Correa-Rotter R, Wesseling C, Johnson RJ. CKD of unknown origin in Central America: the case for a Mesoamerican nephropathy. Am J Kidney Dis 63: 506–520, 2014. doi:10.1053/j.ajkd.2013.10.062.
10. Diggle CP, Shires M, McRae C, Crellin D, Fisher J, Carr IM, Markham AF, Hayward BE, Asipu A, Bonthron DT. Both isoforms of ketohexokinase are dispensable for normal growth and development. Physiol Genomics 42A: 235–243, 2010. doi:10.1152/physiolgenomics. 00128.2010.
11. García-Arroyo FE, Cristóbal M, Arellano-Buendía AS, Osorio H, Tapia E, Soto V, Madero M, Lanaspa MA, Roncal-Jiménez C, Bankir L, Johnson RJ, Sánchez-Lozada LG. Rehydration with soft drink-like beverages exacerbates dehydration and worsens dehydration-associated renal injury. Am J Physiol Regul Integr Comp Physiol 311: R57–R65, 2016. doi:10.1152/ajpregu.00354.2015.
12. García-Trabanino R, Jarquín E, Wesseling C, Johnson RJ, González-Quiroz M, Weiss I, Glaser J, José Vindell J, Stockfelt L, Roncal C, Harra T, Barregard L. Heat stress, dehydration, and kidney function in sugarcane cutters in El Salvador–A cross-shift study of workers at risk of Mesoamerican nephropathy. Environ Res 142: 746–755, 2015. doi:10. 1016/j.envres.2015.07.007.
13. Garcia Trabiano R, Aguilar R, Silva CR, Mercado MO, Merino RL. [End-stage renal disease among patients in a referral hospital in El Salvador] Rev Panam Salud Publica. 12: 202–206, 2002.
14. Glaser J, Lemery J, Rajagopalan B, Diaz HF, Garcia-Trabanino R, Taduri G, Madero M, Amarasinghe MD, Abraham G, Anutrakulchai S, Jha V, Stenvinkel P, Roncal-Jiménez C, Lanaspa M, Correa-Rotter R, Sheik-Hamad D, Burdmann EA, Andres-Hernando A, MIlagres T, Weiss I, Kanbay M, Wesseling C, Sanchez-Lozada LG, Johnson RJ. Climate Change and the Emergent Epidemic of Chronic Kidney Disease from Heat Stress in Rural Communities: The Case for Heat Stress Nephropathy. Clin J Am Soc Nephrol 11: 1472–1483, 2016. doi:10.2215/CJN.13841215.
15. Grgic I, Campanholle G, Bijol V, Wang C, Sabbisetti VS, Ichimura T, Humphreys BD, Bonventre JV. Targeted proximal tubule injury triggers interstitial fibrosis and glomerulosclerosis. Kidney Int 82: 172–183, 2012. doi:10.1038/ki.2012.20.
16. Ikemoto F, Song GB, Tominaga M, Kanayama Y, Yamamoto K. Angiotensin-converting enzyme in the rat kidney. Activity, distribution, and response to angiotensin-converting enzyme inhibitors. Nephron 55, Suppl 1: 3–9, 1990. doi:10.1159/000186027.
17. Johnson RJ, Rodriguez-Iturbe B, Roncal-Jimenez C, Lanaspa MA, Ishimoto T, Nakagawa T, Correa-Rotter R, Wesseling C, Bankir L, Sanchez-Lozada LG. Hyperosmolarity drives hypertension and CKD--water and salt revisited. Nat Rev Nephrol 10: 415–420, 2014. doi:10.1038/nrneph.2014.76.
18. Johnson RJ, Stenvinkel P, Jensen T, Lanaspa MA, Roncal C, Song Z, Bankir L, Sánchez-Lozada LG. Metabolic and kidney diseases in the setting of climate change, water shortage, and survival factors. J Am Soc Nephrol 27: 2247–2256, 2016. doi:10.1681/ASN.2015121314.
19. Khan SQ, Dhillon OS, O’Brien RJ, Struck J, Quinn PA, Morgenthaler NG, Squire IB, Davies JE, Bergmann A, Ng LL. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study. Circulation 115: 2103–2110, 2007. doi:10.1161/CIRCULATIONAHA.106.685503.
20. Ko BC, Ruepp B, Bohren KM, Gabbay KH, Chung SS. Identification and characterization of multiple osmotic response sequences in the human aldose reductase gene. J Biol Chem 272: 16431–16437, 1997. doi:10.1074/jbc.272.26.16431.
21. Lanaspa MA, Almeida NE, Andres-Hernando A, Rivard CJ, Capasso JM, Berl T. The tight junction protein, MUPP1, is up-regulated by hypertonicity and is important in the osmotic stress response in kidney cells. Proc Natl Acad Sci U S A 104: 13672–13677, 2007. doi:10.1073/pnas.0702752104.
22. Lanaspa MA, Ishimoto T, Cicerchi C, Tamura Y, Roncal-Jimenez CA, Chen W, Tanabe K, Andres-Hernando A, Orlicky DJ, Finol E, Inaba S, Li N, Rivard CJ, Kosugi T, Sanchez-Lozada LG, Petrash JM, Sautin YY, Ejaz AA, Kitagawa W, Garcia GE, Bonthron DT, Asipu A, Diggle CP, Rodriguez-Iturbe B, Nakagawa T, Johnson RJ. Endogenous fructose production and fructokinase activation mediate renal injury in diabetic nephropathy. J Am Soc Nephrol 25: 2526–2538, 2014. doi:10.1681/ASN.2013080901.
23. Laws RL, Brooks DR, Amador JJ, Weiner DE, Kaufman JS, Ramírez-Rubio O, Riefkohl A, Scammell MK, López-Pilarte D, Sánchez JM, Parikh CR, McClean MD. Changes in kidney function among Nicaraguan sugarcane workers. Int J Occup Environ Health 21: 241–250, 2015. doi:10.1179/2049396714Y.0000000102.
24. Lee SK, Lanaspa MA, Sánchez-Lozada LG, Johnson RJ. Hyponatre-mia with Persistent Elevated Urinary Fractional Uric Acid Excretion: Evidence for Proximal Tubular Injury? Kidney Blood Press Res 41: 535–544, 2016. doi:10.1159/000447928.
25. Nakayama T, Kosugi T, Gersch M, Connor T, Sanchez-Lozada LG, Lanaspa MA, Roncal C, Perez-Pozo SE, Johnson RJ, Nakagawa T. Dietary fructose causes tubulointerstitial injury in the normal rat kidney. Am J Physiol Renal Physiol 298: F712–F720, 2010. doi:10.1152/ajprenal.00433.2009.
26. Nath KA, Hostetter MK, Hostetter TH. Pathophysiology of chronic tubulo-interstitial disease in rats. Interactions of dietary acid load, ammonia, and complement component C3. J Clin Invest 76: 667–675, 1985. doi:10.1172/JCI112020.
27. Nejat M, Pickering JW, Devarajan P, Bonventre JV, Edelstein CL, Walker RJ, Endre ZH. Some biomarkers of acute kidney injury are increased in pre-renal acute injury. Kidney Int 81: 1254–1262, 2012. doi:10.1038/ki.2012.23.
28. Roncal CA, Mu W, Croker B, Reungjui S, Ouyang X, Tabah-Fisch I, Johnson RJ, Ejaz AA. Effect of elevated serum uric acid on cisplatin-induced acute renal failure. Am J Physiol Renal Physiol 292: F116–F122, 2007. doi:10.1152/ajprenal.00160.2006.
29. Roncal-Jimenez C, García-Trabanino R, Barregard L, Lanaspa MA, Wesseling C, Harra T, Aragón A, Grases F, Jarquin ER, González MA, Weiss I, Glaser J, Sánchez-Lozada LG, Johnson RJ. Heat Stress Nephropathy From Exercise-Induced Uric Acid Crystalluria: A Perspective on Mesoamerican Nephropathy. Am J Kidney Dis 67: 20–30, 2016. doi:10.1053/j.ajkd.2015.08.021.
30. Roncal Jimenez CA, Ishimoto T, Lanaspa MA, Rivard CJ, Nakagawa T, Ejaz AA, Cicerchi C, Inaba S, Le M, Miyazaki M, Glaser J, Correa-Rotter R, González MA, Aragón A, Wesseling C, Sánchez-Lozada LG, Johnson RJ. Fructokinase activity mediates dehydration-induced renal injury. Kidney Int 86: 294–302, 2014. doi:10.1038/ki.2013.492.
31. Ruepp B, Bohren KM, Gabbay KH. Characterization of the osmotic response element of the human aldose reductase gene promoter. Proc Natl Acad Sci U S A 93: 8624–8629, 1996. doi:10.1073/pnas.93.16.8624.
32. Takahashi N, Boysen G, Li F, Li Y, Swenberg JA. Tandem mass spectrometry measurements of creatinine in mouse plasma and urine for determining glomerular filtration rate. Kidney Int 71: 266–271, 2007. doi:10.1038/sj.ki.5002033.
33. Wesseling C, Aragón A, González M, Weiss I, Glaser J, Bobadilla NA, Roncal-Jiménez C, Correa-Rotter R, Johnson RJ, Barregard L. Kidney function in sugarcane cutters in Nicaragua--A longitudinal study of workers at risk of Mesoamerican nephropathy. Environ Res 147: 125–132, 2016. doi:10.1016/j.envres.2016.02.002.
34. Wijkström J, Leiva R, Elinder CG, Leiva S, Trujillo Z, Trujillo L, Söderberg M, Hultenby K, Wernerson A. Clinical and pathological characterization of Mesoamerican nephropathy: a new kidney disease in Central America. Am J Kidney Dis 62: 908–918, 2013. doi:10.1053/j.ajkd.2013.05.019.
35. Wolf JP, Nguyen NU, Dumoulin G, Berthelay S. Influence of hypertonic monosaccharide infusions on the release of plasma arginine vasopressin in normal humans. Horm Metab Res 24: 379–383, 1992. doi:10.1055/s-2007-1003340.
36. Yang B, Bankir L. Urea and urine concentrating ability: new insights from studies in mice. Am J Physiol Renal Physiol 288: F881–F896, 2005. doi:10.1152/ajprenal.00367.2004.